NDC 51672-1402-08 - Calcipotriene and Betamethasone Dipropionate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-1402
- Requested NDC
- 51672-1402-08
- Package NDCs from labels
- 51672-1402-4, 51672-1402-8, 51672-1402-08
- Manufacturer
- Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc.
- Effective date
- 2025-07-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| MINERAL OIL - Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc. | Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc. | 2025-07-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-1402-4 | Calcipotriene and Betamethasone Dipropionate | 60 g in 1 BOTTLE | SUSPENSION | 60 | 2 | |
| 51672-1402-4 | Calcipotriene and Betamethasone Dipropionate | 1 in 1 CARTON | SUSPENSION | 1 | 2 | |
| 51672-1402-8 | Calcipotriene and Betamethasone Dipropionate | 60 g in 1 BOTTLE | SUSPENSION | 60 | 2 | |
| 51672-1402-8 | Calcipotriene and Betamethasone Dipropionate | 2 in 1 CARTON | SUSPENSION | 2 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-1402 | CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE SUSPENSION [TARO PHARMACEUTICALS U.S.A., INC.] | 1 | Current NDC, Legacy NDC, 4 package rows | 20200904_1d0ab2e6-1ab1-4d3e-ad55-7fa26446f191.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Clotrimazole and Betamethasone Dipropionate | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | Sun Pharmaceutical Industries, Inc. | e4e9f244-4a85-4c0d-9917-93182c4a6e87 | 2025-07-07 | Adverse reactions | 826Y60901U |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | Sun Pharmaceutical Industries, Inc. | 3b23a3c0-3306-4a2d-932d-25916d16dc68 | 2025-07-07 | Warnings, Adverse reactions | 826Y60901U |
| Betamethasone dipropionate | BETAMETHASONE DIPROPIONATE | Sun Pharmaceutical Industries, Inc. | dc3dd2f7-38ad-4c4c-8602-29b33cc6af90 | 2025-07-07 | Warnings, Adverse reactions | 826Y60901U |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | Sun Pharmaceutical Industries, Inc. | bc12c828-54ba-411d-b752-9b735f7adf63 | 2025-07-02 | Adverse reactions | 826Y60901U |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | Sun Pharmaceutical Industries, Inc. | e041ceb2-8bda-4703-b663-804e7b462e32 | 2025-07-02 | Adverse reactions | 826Y60901U |
| Calcipotriene and Betamethasone Dipropionate | CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE | Sun Pharmaceutical Industries, Inc. | 1d0ab2e6-1ab1-4d3e-ad55-7fa26446f191 | 2025-07-01 | Warnings, Adverse reactions | ANDA213269 51672-1402-4 51672-1402-8 51672-1402 51672140208 38e5b828-cecd-c95b-e063-6394a90ae2e0 1d0ab2e6-1ab1-4d3e-ad55-7fa26446f191 143NQ3779B 826Y60901U |
| ProCure Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Twin Med LLC | 37a4cc43-0d53-f1bf-e063-6394a90a2dc9 | 2025-06-15 | Warnings | T5L8T28FGP |
| Hemorrhoidal Pain Relief | HEMORRHOIDAL PAIN RELIEF OINTMENT | Neilmed Pharmaceuticals Inc. | 374d89b6-9305-9adf-e063-6394a90adb32 | 2025-06-11 | Warnings | T5L8T28FGP |
| HemorrhoidalOintment | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCI | Trifecta Pharmaceuticals USA LLC | 4eb3c9ac-268a-5246-e054-00144ff88e88 | 2025-06-09 | Warnings | T5L8T28FGP |
| Mineral Oil | MINERAL OIL | ATLANTIC BIOLOGICALS CORP. | 960502ae-2468-406e-8799-cacb01f2727e | 2025-05-23 | Warnings | T5L8T28FGP |
| Mineral Oil | MINERAL OIL | AmerisourceBergen (Good Neighbor Pharmacy) 46122 | 581f81a0-7488-4c90-b33e-06c6301a4fd2 | 2025-04-17 | Warnings | T5L8T28FGP |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | NuCare Pharmaceuticals,Inc. | 75862805-2cfc-fb45-e053-2991aa0a1403 | 2025-04-03 | Warnings, Adverse reactions | 826Y60901U |
| Betamethasone dipropionate | BETAMETHASONE DIPROPIONATE | A-S Medication Solutions | 07a35811-7298-4f25-b280-e2f9aeab9830 | 2025-04-01 | Adverse reactions | 826Y60901U |
| hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Bionpharma Inc. | 1790da99-2a22-e2a2-e063-6394a90ac36f | 2025-03-31 | Warnings | T5L8T28FGP |
| Dr. Butler Hemorrhoid and Perineal | MINERAL OIL 59.8%,PETROLATUM 36% | Beyond Health P.A. | d17b6f16-6893-ce0a-e053-2a95a90aa23a | 2025-03-19 | Warnings | T5L8T28FGP |
| Mineral Oil | MINERAL OIL | Kesin Pharma Corporation | 30a11cc9-e407-23b7-e063-6294a90a7d6e | 2025-03-18 | Warnings | T5L8T28FGP |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | A-S Medication Solutions | 018fcec3-bfb4-451c-9b54-d1fd389c2a44 | 2025-03-14 | Warnings, Adverse reactions | 826Y60901U |
| Mineral oil | MINERAL OIL | P & L Development, LLC | 68e88119-1468-4ab7-a5fa-242d960d25df | 2025-02-21 | Warnings | T5L8T28FGP |
| Mineral oil | MINERAL OIL | Best Choice (Valu Merchandisers Company) | 3ec8a716-60e0-4dfb-adae-ddc53c613935 | 2025-02-04 | Warnings | T5L8T28FGP |
| Hemorrhoidal | PAIN RELIEF | NeilMed Pharmaceuticals Inc. | 038a2cf5-1b72-227b-e063-6394a90a84ad | 2025-01-24 | Warnings | T5L8T28FGP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.